COL22516-showcase
Enabling tomorrow's oncology breakthroughs today

Research into cancer genomics is advancing our understanding of cancer development and progression, including the identification of cancer driver events.

To discover the breakthrough, you must be ready to handle the most urgent challenges:

  • Uncovering cryptic tumor heterogeneity
  • Extracting data from limited or challenging samples, such as formalin-fixed paraffin-embedded (FFPE) tissue or cell-free DNA (cfDNA) samples
  • Analyzing and extracting key insights from vast amounts of data generated by multiple technologies
  • Choosing the right technology for each stage of biomarker discovery and verification.

Thermo Fisher Scientific offers a variety of cancer genomics research solutions for comprehensive sample profiling, biomarker discovery and verification, and data analysis.

Cancer genomics solutions

With access to these innovative products and platforms, you can uncover the genetic variants and RNA signatures you need to power your next breakthrough.

Targeted NGS solutions for cancer research

Accelerate your cancer research with our Oncomine assays and Ion AmpliSeq technology and panels.

Whole-genome copy number analysis

Microarrays are the platform of choice for detecting DNA structural variants (SV) such as chromosome insertions, duplications, and deletions.

Liquid biopsy research

The Oncomine cfTNA solutions combined with TaqMan Digital PCR Liquid Biopsy assays, offer a comprehensive set of tools for liquid biopsy applications, and in the future may enable noninvasive techniques towards personalized medicine.

Cancer RNA expression

Choose from a variety of RNA expression analysis tools for fast, simple analysis of coding as well as short and long noncoding RNAs to uncover new RNA biomarker signatures.

Cancer genotyping assays: somatic and germline

Accurately screen or confirm somatic and germline variants of choice using sequencing and real-time PCR.

Whole exome sequencing

Discover new biomarkers for cancer research using exome sequencing.

Cancer epigenetics

Identify epigenetic changes that occur during tumor progression.

Laser capture microdissection

Isolate pure populations of cancer cells from tumor tissues.